Table 3.
Department/Agency | Primary Purpose of Funds | Appropriations Amount |
---|---|---|
HHS, Food and Drug Administration (FDA) | Review, regulation, and postmarket surveillance of MCMs, and administrative activities | 25 |
Department of Defense (DoD) | $17 million for MCM procurement and $95 million for MCM RDT&E | 112 |
NIH, National Institute of Allergy and Infectious Diseases (NIAID) | Ebola countermeasures R&D | 238 |
HHS Office of the Secretary (PHSSEF) (BARDA) | To develop and purchase countermeasures, vaccines, diagnostics, and medical supplies | 733 |
Total | 1,108.00 |
Note. Adapted from the text of H.R. 83, the Consolidated and Further Continuing Appropriations Act, 2015.30